These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36524444)

  • 1. Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019.
    Black E; Mammen K; Deacon RM; Ezard N; Mills L; Dunlop AJ; Montebello M; Reid D; Childs S; Bruno R; Shakeshaft A; Siefried KJ; Farrell M; Holmes J; Lintzeris N
    Drug Alcohol Rev; 2023 Feb; 42(2):389-400. PubMed ID: 36524444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study.
    Black E; Bruno R; Mammen K; Mills L; Siefried KJ; Deacon RM; Shakeshaft A; Dunlop AJ; Ezard N; Montebello M; Childs S; Reid D; Holmes J; Lintzeris N
    Med J Aust; 2023 Sep; 219(5):218-226. PubMed ID: 37449648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine-Type Stimulant Dependence and Association with Concurrent Use of Cocaine, Alcohol, and Cannabis: A Cross-Sectional Study.
    Berndt S; Rosenkranz M; Martens MS; Verthein U
    Eur Addict Res; 2022; 28(2):113-121. PubMed ID: 34788752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use, health status and service utilisation of older clients attending specialist drug and alcohol services.
    Lintzeris N; Rivas C; Monds LA; Leung S; Withall A; Draper B
    Drug Alcohol Rev; 2016 Mar; 35(2):223-31. PubMed ID: 26498741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of treatment provided for amphetamine use in New South Wales, Australia.
    McKetin R; Kelly E; Indig D
    Drug Alcohol Rev; 2005 Sep; 24(5):433-6. PubMed ID: 16298838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Look west for Australian evidence of the relationship between amphetamine-type stimulant prescribing and meth/amphetamine use.
    Whitely M; Allsop S
    Drug Alcohol Rev; 2020 Jul; 39(5):519-524. PubMed ID: 32314469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysubstance use in young people accessing residential and day-treatment services for substance use: substance use profiles, psychiatric comorbidity and treatment completion.
    Mefodeva V; Carlyle M; Walter Z; Chan G; Hides L
    Addiction; 2022 Dec; 117(12):3110-3120. PubMed ID: 35851706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the complexity, patterns, and correlates of alcohol and other substance use among young people seeking help for mental ill-health.
    Gao CX; Filia KM; Bedi G; Menssink JM; Brown E; Rickwood DJ; Parker AG; Hetrick SE; Herrman H; Hickie I; Telford N; McGorry PD; Cotton SM
    Soc Psychiatry Psychiatr Epidemiol; 2023 Oct; 58(10):1457-1467. PubMed ID: 36914881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rising threat of illicit amphetamine-type stimulant use among methadone maintenance treatment patients in East Coast Malaysia: a retrospective observational study.
    Ismail H; Ahmad H; Sanef A; Shahabudin W; Reffin N; Chan D; Dawam D; Hanan F; Nordin M; Sahar L; Daud K; Bongsu KT; Syezri F; Mustapa H
    Am J Drug Alcohol Abuse; 2023 Jan; 49(1):97-108. PubMed ID: 36786756
    [No Abstract]   [Full Text] [Related]  

  • 10. Simultaneous use of alcohol with methamphetamine but not ecstasy linked with aggression among young adult stimulant users.
    Leslie EM; Smirnov A; Cherney A; Wells H; Legosz M; Kemp R; Najman JM
    Addict Behav; 2017 Jul; 70():27-34. PubMed ID: 28182965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased demand for amphetamine treatment in rural Australia.
    Allan J; Ip RHL; Kemp M; Snowdon N
    Addict Sci Clin Pract; 2019 Apr; 14(1):13. PubMed ID: 30929641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of clients entering women-only substance use treatment services in New South Wales.
    Uthurralt N; Miao Cao F; Reid SE; Nithyanandam L; Burns L; Day CA
    Womens Health (Lond); 2023; 19():17455057231200133. PubMed ID: 37921428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of individuals presenting to treatment for primary alcohol problems versus other drug problems in the Australian patient pathways study.
    Lubman DI; Garfield JB; Manning V; Berends L; Best D; Mugavin JM; Lam T; Buykx P; Larner A; Lloyd B; Room R; Allsop S
    BMC Psychiatry; 2016 Jul; 16():250. PubMed ID: 27435013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysubstance use classes and health outcomes among women attending specialist substance use treatment services.
    Rodriguez AS; Robinson LD; Kelly PJ; Hudson S
    Drug Alcohol Rev; 2022 Feb; 41(2):488-500. PubMed ID: 34405938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance Use and Co-occurring Physical Health Problems: File Review of a Residential Drug and Alcohol Treatment Service.
    Osborne B; Kelly PJ; Larance B; Robinson LD; Ivers R; Deane FP; Webber A; Kelly D
    J Dual Diagn; 2020; 16(2):250-259. PubMed ID: 31877110
    [No Abstract]   [Full Text] [Related]  

  • 16. Individual, Social, and Environmental Factors Associated with Different Patterns of Stimulant Use: A Cross-Sectional Study from Five European Countries.
    Rosenkranz M; O'Donnell A; Martens MS; Zurhold H; Degkwitz P; Liebregts N; Barták M; Rowicka M; Verthein U
    Eur Addict Res; 2023; 29(3):182-193. PubMed ID: 37166303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedicated 'cannabis only' treatment clinics in New South Wales, Australia: client and treatment characteristics and associations with first-time treatment seeking.
    Copeland J; Allsop D
    Drug Alcohol Rev; 2014 Sep; 33(5):565-71. PubMed ID: 24902861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of mental health disorders among young adults who use amphetamine-type stimulants, compared to young adults who do not.
    Thoradeniya MR; Wessel EL; Pourmarzi D; Najman JM; Smirnov A
    Drug Alcohol Rev; 2021 May; 40(4):557-566. PubMed ID: 33073466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality.
    Havard A; Jones N; Bharat C; Gisev N; Pearson SA; Shakeshaft A; Farrell M; Degenhardt L
    Drug Alcohol Rev; 2023 Sep; 42(6):1461-1471. PubMed ID: 37186492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polysubstance use in treatment seekers who inject amphetamine: Drug use profiles, injecting practices and quality of life.
    Kelly PJ; Robinson LD; Baker AL; Deane FP; McKetin R; Hudson S; Keane C
    Addict Behav; 2017 Aug; 71():25-30. PubMed ID: 28242532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.